CelLBxHealth plc（ANPCY）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · ANPCY · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2024-12	2023-12	2022-12	2021-12	2020-12
Revenue
Revenue	$2.86M	$2.19M	$1.04M	$1.01M	$0.76M
Cost of Revenue	$1.08M	$2.59M	$0.43M	$0.30M	$0.17M
Gross Profit	$1.78M	($0.41M)	$0.61M	$0.71M	$0.60M
Gross Margin %(computed)	62.16%	-18.66%	58.89%	70.19%	78.35%
Operating Expenses
R&D Expenses	$1.77M	$9.51M	$10.81M	$8.48M	$7.88M
G&A Expenses	$0.46M	$0.38M	$0.56M	$0.34M	$0.37M
Total Operating Expenses	$16.88M	$21.35M	$24.82M	$17.95M	$14.33M
Operating Income	($15.10M)	($21.76M)	($24.21M)	($17.23M)	($13.73M)
Operating Margin %(computed)	-527.46%	-995.38%	—	—	—
Interest Income	$0.40M	$0.46M	$0.14M	$0.03M	$0.08M
Interest Expense	$0.31M	$0.33M	$0.35M	$0.16M	$0.09M
Income Before Tax	($15.03M)	($21.63M)	($24.44M)	($17.36M)	($13.74M)
Income Tax Expense	($0.80M)	($1.50M)	($2.75M)	($2.35M)	($2.14M)
Net Income	($14.22M)	($20.13M)	($21.69M)	($15.01M)	($11.61M)
Net Margin %(computed)	-497.03%	-920.95%	—	—	—
Per Share & EBITDA
EPS (Basic)	$-0.48	$-0.77	$-0.88	$-0.67	$-0.65
Wtd Avg Shares	29.49M	26.04M	24.66M	22.51M	17.80M
EBITDA	($13.02M)	($19.00M)	($24.39M)	($15.72M)	($12.23M)
EBITDA Margin %(computed)	-455.07%	-869.12%	—	—	—